Addiction

QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay

Retrieved on: 
Wednesday, April 10, 2024
Science, Biotechnology, Research, Pharmaceutical, Medical Supplies, Health, Medical Devices, Hospitals, Urine, Addiction, Mortality, University, Fentanyl, Risk, Hospital, CDC, 7600, UMD, XT, Substance Abuse, Fatality, Medicine, Multimedia, Maryland School, Assistant, QuidelOrtho, Pharmaceutical industry

QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”).

Key Points: 
  • QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”).
  • This Fentanyl assay will help hospital and emergency room customers respond to the critical demand for enhanced opioid testing, allowing on-site fentanyl testing in less than 10 minutes to aid in immediate clinical decisions.
  • As part of QuidelOrtho’s Vitros systems’ menu of assays, the test offers clinical fentanyl testing for hospitals and emergency departments, providing an effective approach to preliminary urine drug testing.
  • When patients test positive for opioids on a standard drug test, they’re usually directed to drug treatment programs.

ClickReady Introduces Innovative Digital Marketing Plan for Addiction Recovery Centers

Retrieved on: 
Friday, April 26, 2024
Content creation, Addiction, PPC, Internet, Responsive web design, Patient

ATLANTA, April 26, 2024 /PRNewswire-PRWeb/ -- With an increasing number of individuals turning to the internet to find reputable and effective addiction treatment options, ClickReady recognizes the urgent need for specialized marketing strategies that resonate with those seeking help. The new digital marketing plan introduces a suite of services tailored to the unique needs of Addiction Recovery Centers, including advanced SEO tactics, targeted PPC campaigns, engaging content creation, and responsive web design.

Key Points: 
  • ClickReady, a leading digital marketing agency known for its innovative approaches to enhancing online visibility, is proud to announce the launch of a new digital marketing plan and strategy exclusively designed for Addiction Recovery Centers.
  • This comprehensive plan aims to revolutionize the way addiction recovery centers connect with individuals in need, leveraging cutting-edge digital marketing techniques to increase outreach and facilitate meaningful engagements.
  • The new digital marketing plan introduces a suite of services tailored to the unique needs of Addiction Recovery Centers, including advanced SEO tactics, targeted PPC campaigns, engaging content creation, and responsive web design.
  • For more information about ClickReady's new digital marketing plan for Addiction Recovery Centers, visit https://www.clickready.com/ for more information.

University of Toronto scientists appointed as GSK chairs will advance drug delivery research and vaccine education tools for healthcare professionals

Retrieved on: 
Tuesday, April 23, 2024
Education, Addiction, University, Vaccination, Public, Pain, Cancer, Pharmacist, Cell, Attenuated vaccine, Fear, World Health Organization, The Hospital, Teaching, Infection, DSM-IV codes, University of Toronto, RNA, Research, Vaccine, CAMH, Therapy, Algorithm, Pressure, Mental health, GSK, CARD, COVID-19, Chemistry, Comfort, Genome, Health, Messenger, Student, Drug discovery, Dicarboxylic acid, Organization, Deep learning, Pharmaceutical industry

MISSISSAUGA, ON, April 23, 2024 /CNW/ - The University of Toronto's Leslie Dan Faculty of Pharmacy has announced the appointments of two leading scientists as endowed GSK research chairs.

Key Points: 
  • MISSISSAUGA, ON, April 23, 2024 /CNW/ - The University of Toronto's Leslie Dan Faculty of Pharmacy has announced the appointments of two leading scientists as endowed GSK research chairs.
  • Bowen Li, assistant professor at the Leslie Dan Faculty of Pharmacy, University of Toronto, and the Canada Research Chair in RNA Vaccines & Therapeutics is the new GSK Chair in Pharmaceutics and Drug Delivery.
  • They enable continuous advancement in research and teaching and signify a long-term commitment to a specific area of impact.
  • The GSK Chair in Vaccine Education and Practice-Oriented Tools was established by GSK and the Leslie Dan Faculty of Pharmacy in 2023 through a joint investment of $ 3 million.

Shulgin Farm Announces Seed Crystal Campaign to Preserve Psychedelic History and Build Community Hub

Retrieved on: 
Thursday, April 18, 2024
Psilocybin, Spirituality, Dream, Johns Hopkins, PTSD, PiHKAL, Research, Depression, NYU, Knowledge, MDMA, Addiction, Consciousness, TiHKAL, Empathy, Farm, Shulgin, Growth, Nightclub

LAFAYETTE, Calif., April 18, 2024 /PRNewswire-PRWeb/ -- The Shulgin Farm, the legendary site where Alexander "Sasha" Shulgin synthesized and, together with his wife Ann Shulgin, studied over 200 psychedelic compounds, is embarking on a new chapter. The nonprofit organization has announced the Seed Crystal Campaign to transform the Farm into a center for educational and community-focused events, formal and informal gatherings, and historic preservation.

Key Points: 
  • The nonprofit organization has announced the Seed Crystal Campaign to transform the Farm into a center for educational and community-focused events, formal and informal gatherings, and historic preservation.
  • Now, the psychedelic community has the chance to continue the Shulgins' journey of discovery by supporting Shulgin Farm's preservation and evolution.
  • The Seed Crystal Campaign , named after the catalytic role of seed crystals in sparking growth, aims to raise $3 million to establish the Farm as a psychedelic cultural center.
  • To learn more about the Seed Crystal Campaign or make a donation, visit shulginfarm.org or contact [email protected] .

Virtue Recovery Offers Holistic Therapy Options for Enhanced Rehabilitation

Retrieved on: 
Wednesday, April 10, 2024
Patient, CDO, Ice, Hope, Holism, Blood pressure, MAT, Health, Steam, Research, Water, Hydrotherapy, Skin temperature, Heart rate, Psychotherapy, Yoga, Disease, Fasting, Mental health, Addiction, Mindfulness, Breathing, Cognitive behavioral therapy, Music, Meditation, Music therapy, Rehabilitation, CBT, Walking, Virtue, Swimming, Nursing

LAS VEGAS, April 10, 2024 /PRNewswire-PRWeb/ --

Key Points: 
  • Virtue Recovery Center is proud to announce an expanded suite of holistic therapy options designed to complement its evidence-based rehabilitation programs.
  • Embracing a comprehensive path to recovery, Virtue Recovery Center integrates innovative, traditional, and additional therapies, including holistic approaches to nurture the mind, body, and spirit.
  • "Virtue Recovery Center embraces the addition of a holistic treatment approach because we understand that recovery transcends the physical aspect of addiction.
  • Virtue Recovery Center's methodology embraces the integration of traditional rehabilitation with holistic therapies, emphasizing a holistic and evidence-based care approach aimed at treating the full spectrum of addiction.

RECOVERY CENTERS OF AMERICA, LAW FIRM OBERMAYER REBMANN MAXWELL & HIPPEL, AND THE HYER CALLING FOUNDATION ANNOUNCE INAUGURAL EVENT ADVOCATING FOR LEGAL RECOVERY COMMUNITY

Retrieved on: 
Tuesday, April 9, 2024
Well, CLE, Employment, Partnership, Patient, Lawyer, Senior counsel, Insurance, Life, HCF, Addiction, Workplace, Alumni association, Obermayer, RCA, Nursing

King of Prussia, PA, April 09, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA, PA -- Recovery Centers of America ( www.RecoveryCentersofAmerica.com ), together with The Hyer Calling Foundation, ( www.hyercalling.org ) announce their inaugural event advocating for the legal recovery community on May 8 at 2pm at RCA’s Devon location.

Key Points: 
  • King of Prussia, PA, April 09, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA, PA -- Recovery Centers of America ( www.RecoveryCentersofAmerica.com ), together with The Hyer Calling Foundation, ( www.hyercalling.org ) announce their inaugural event advocating for the legal recovery community on May 8 at 2pm at RCA’s Devon location.
  • The event is specifically scheduled for the middle of Lawyer Well Being Week.
  • As the gold standard in SUD treatment and co-occurring mental health conditions, RCA has always had a robust Alumni Association providing former patients in recovery an ongoing support system.
  • For media inquiries or interviews please contact Nina Zucker Associates at 610.457.4387 or [email protected] , Maureen Keown at 610.496.6290 or [email protected] or Dineo Thompson at [email protected] at 215.

Clearmind Medicine CEO Issues Letter to Shareholders

Retrieved on: 
Tuesday, April 9, 2024
Data monitoring committee, Depression, Obesity, Mevalonate pathway, Psychiatry, Dyskinesia, Addiction, Safety, Binge drinking, Data, DSM-IV codes, Research, MEAI, Clinical trial, Johns Hopkins University, Phase, Patent, Therapy, Ministry, FDA, Impulsivity, CTS, IRB, Pharmaceutical industry

Recently, our efforts reached a key inflection point as the Israeli Ministry of Health approved our Phase I/IIa clinical trial for CMND-100 for AUD.

Key Points: 
  • Recently, our efforts reached a key inflection point as the Israeli Ministry of Health approved our Phase I/IIa clinical trial for CMND-100 for AUD.
  • CMND-100, a pioneering MEAI-based (5-methoxy-2-aminoindane) formula, has exhibited encouraging results in pre-clinical studies.
  • Notably, it has shown the ability to disrupt the destructive cycle of binge drinking without inducing hallucinations—a common concern with existing treatments.
  • The journey ahead is filled with potential, and we eagerly anticipate sharing impactful updates with our shareholders."

The Canadian Centre on Substance Use and Addiction Welcomes Scott Elliott to its Board of Directors

Retrieved on: 
Monday, April 8, 2024
Addiction, Mental health, Chair, Substance, HIV, Knowledge, The Honourable, Research, Health Canada, Parliament, DSM-IV codes, CCSA

“Scott is known for his efforts in tackling substance use health issues and finding unique, powerful solutions.

Key Points: 
  • “Scott is known for his efforts in tackling substance use health issues and finding unique, powerful solutions.
  • Mr. Elliott is the Chief Executive Officer of the Dr. Peter Centre in Vancouver, B.C.
  • The Centre provides clinical, social and psychological support to marginalized community members living with HIV, complex medical conditions, mental illness, and substance use and addictions.
  • “People in Canada will benefit from Scott’s understanding of community building and the diverse experiences across substance use health.”
    Mr. Elliott joins 12 other directors to complete CCSA’s volunteer Board of Directors.

Partnership for a Drug-Free New Jersey’s Opioid Prevention Initiatives Recognized at National Rx Summit

Retrieved on: 
Thursday, April 4, 2024
Prohibition, Mental health, Organization, Communication, Partnership, COVID-19, Patient, Knowledge, Human services, Volunteering, Advertising, Substance use disorder, Addiction, Poster, Government, Knockout, Cryptocurrency

PDFNJ highlighted these initiatives, which are critical in providing New Jersey communities with vital information on preventing opioid misuse, as part of the Rx Summit’s poster sessions.

Key Points: 
  • PDFNJ highlighted these initiatives, which are critical in providing New Jersey communities with vital information on preventing opioid misuse, as part of the Rx Summit’s poster sessions.
  • Through this program, more than 10,000 volunteers throughout the state share opioid prevention and awareness messages and materials.
  • “At the Rx Summit, we shared our strategies for reaching New Jersey communities with essential information on preventing opioid misuse,” said Angelo Valente, Executive Director of PDFNJ.
  • Since its inception, the Partnership has garnered 226 advertising and public relations awards from national, regional and statewide media organizations.

Inspiring Hope Together: Canadian Association for Suicide Prevention Announces National Suicide Prevention Conference in Vancouver, BC

Retrieved on: 
Thursday, April 4, 2024
SDP, Mental health, Conference, Communication, CASP, LivingWorks, CAMH, Suicide, Death, Addiction, Root, Nursing

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the "Inspiring Hope Together" National Suicide Prevention Conference, scheduled to take place from May 29 to May 31, 2024, at the prestigious Pinnacle Hotel Harbourfront in Vancouver, BC.

Key Points: 
  • VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the "Inspiring Hope Together" National Suicide Prevention Conference, scheduled to take place from May 29 to May 31, 2024, at the prestigious Pinnacle Hotel Harbourfront in Vancouver, BC.
  • The theme of the conference, “Inspiring Hope Together,” emphasizes the transformative power of unity and the collective strength necessary to effect positive change in our communities.
  • Join us as we Inspire Hope Together and chart a course towards a brighter future in suicide prevention.
  • With support from Inspiring Hope Ally Sponsors, LivingWorks, Mental Health Commission of Canada (MHCC), Services de Développement Professionnels (SDP), and Roots of Hope, the National Suicide Prevention Conference is the premiere Canadian event for exchanging knowledge on suicide prevention, intervention, postvention, and life promotion, not to be missed!